Log in
Enquire now
CardiaTec

CardiaTec

CardiaTec is an AI-powered cardiovascular drug discovery platform founded in 2021 by Thelma Zablocki, Raphael Peralta and Namshik Han.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
B2X
B2B
B2B
CEO
‌
Raphael Peralta
COO
‌
Thelma Zablocki
Country
United Kingdom
United Kingdom
CTO
‌
Namshik Han
Email Address
info@cardiatec.ai
Founded Date
January 1, 2021
Founder
‌
Namshik Han
‌
Thelma Zablocki
‌
Raphael Peralta
Funding Type
Pre-Seed
Pre-Seed
Headquarters
Cambridge, Cambridgeshire
Cambridge, Cambridgeshire
Industry
Cardiology
Cardiology
Artificial Intelligence (AI)
Artificial Intelligence (AI)
Drug discovery
Drug discovery
Pharmaceutical industry
Pharmaceutical industry
Health technology
Health technology
‌
Deep Tech
Biotechnology
Biotechnology
Cardiovascular disease
Cardiovascular disease
Investors
Montage Ventures
Montage Ventures
APEX Ventures
APEX Ventures
‌
Continuum Health Ventures
LinkedIn
LinkedIn
‌
Laidlaw Foundation
Latest Funding Round Date
September 10, 2024
Latest Funding Round Amount (USD)
6,500,000
Latest Funding Type
Seed
Seed
LinkedIn URL
@company/cardiatec
Location
United Kingdom
United Kingdom
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
8,200,000
Official Website
cardiatec.ai

Find more companies like CardiaTec

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.